Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q2- Text added to 2020 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
New words:
adultswith, affectedby, April, availableat, Canadian, carcinogenicity, Circuit, clinicaltrial, Companyrecognized, completeda, DailyLiving, Eleventh, ev, fromour, idence, impactthat, injunctive, intention, Jersey, judicial, KYE, LLC, Medunik, Monograph, NOC, nonclinical, Notice, ourresponse, PantherRx, Pennsylvania, pharmacy, pivotal, receivedan, reproductive, requested, sought, stopthe, suitable, supposed, telephoneand, thefight, throughthe, toNorthwestern, toreport, toxicity, unreasonable, USPTO, Western
Valuein 2020 Q2 filing- Value in 2020 Q3 filing
Original filings
Filing view